1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 23
1.3.2 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY 24
1.5 STAKEHOLDERS 25

2 RESEARCH METHODOLOGY 26
2.1 RESEARCH APPROACH 26
2.1.1 SECONDARY DATA 27
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 29
2.1.2.1 Key data from primary sources 30
2.1.2.2 Key industry insights 31
2.2 MARKET SIZE ESTIMATION 32
2.2.1 BOTTOM-UP APPROACH 33
2.2.2 TOP-DOWN APPROACH 33
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 34
2.4 MARKET SHARE ESTIMATION 35
2.5 LIMITATIONS 35
2.6 ASSUMPTIONS FOR THE STUDY 35

3 EXECUTIVE SUMMARY 37

4 PREMIUM INSIGHTS 42
4.1 INFUSION PUMPS: MARKET OVERVIEW 42
4.2 APAC: INFUSION PUMPS MARKET, BY END USER (2017) 43
4.3 GEOGRAPHICAL SNAPSHOT OF THE INFUSION PUMPS MARKET 44
4.4 INFUSION PUMPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 45
4.5 INFUSION PUMPS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 46

5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
5.2.1 MARKET DRIVERS 48
5.2.1.1 Rising demand for ambulatory infusion pumps 48
5.2.1.2 Increasing incidence of chronic diseases along with the rapid growth in the geriatric population 48
5.2.1.3 Growing number of surgical procedures performed 50
5.2.2 MARKET RESTRAINTS 51
5.2.2.1 Frequent product recalls of infusion pumps 51
5.2.2.2 Stringent regulatory requirements for new products 52
5.2.2.3 Increasing adoption of refurbished and rental infusion pumps 52
5.2.3 MARKET OPPORTUNITIES 53
5.2.3.1 Emerging markets 53
5.2.3.2 Growing adoption of specialty infusion systems 54
5.2.4 MARKET CHALLENGES 55
5.2.4.1 Increasing incidence of medication errors and lack of wireless connectivity in most hospitals 55

6 INDUSTRY INSIGHTS 56
6.1 INTRODUCTION 56
6.2 PORTER’S FIVE FORCES ANALYSIS 56
6.2.1 THREAT OF NEW ENTRANTS 57
6.2.2 THREAT OF SUBSTITUTES 58
6.2.3 BARGAINING POWER OF SUPPLIERS 58
6.2.4 BARGAINING POWER OF BUYERS 58
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 58
6.3 PRODUCT BENCMARKING 59

7 REGULATORY ANALYSIS 62
7.1 INTRODUCTION 62
7.1.1 NORTH AMERICA 62
7.1.1.1 US 62
7.1.1.2 Canada 64
7.1.2 EUROPE 65
7.1.3 APAC 66
7.1.3.1 Japan 66
7.1.3.2 China 67
7.1.3.3 India 68
7.1.4 LATIN AMERICA 68
7.1.4.1 Brazil 69
7.1.4.2 Mexico 71

8 INFUSION PUMPS MARKET, BY PRODUCT 73
8.1 INTRODUCTION 74
8.2 DEVICES 76
8.2.1 VOLUMETRIC INFUSION PUMPS 79
8.2.2 SYRINGE INFUSION PUMPS 82
8.2.3 INSULIN INFUSION PUMPS 85
8.2.4 AMBULATORY INFUSION PUMPS 88
8.2.4.1 Disposable infusion pumps 91
8.2.4.2 Chemotherapy infusion pumps 93
8.2.5 ENTERAL INFUSION PUMPS 94
8.2.6 PCA INFUSION PUMPS 96
8.2.7 IMPLANTABLE INFUSION PUMPS 98
8.3 INFUSION PUMP ACCESSORIES/CONSUMABLES 100
8.3.1 DEDICATED ACCESSORIES/CONSUMABLES 104
8.3.1.1 Volumetric infusion pump accessories/consumables 106
8.3.1.2 Enteral infusion pump accessories/consumables 108
8.3.1.3 Insulin infusion pump accessories/consumables 109
8.3.1.4 Syringe infusion pump accessories/consumables 110
8.3.1.5 Ambulatory infusion pump accessories/consumables 111
8.3.1.6 PCA pump accessories/consumables 112
8.3.1.7 Implantable infusion pump accessories/consumables 113
8.3.2 NON-DEDICATED ACCESSORIES/CONSUMABLES 114
8.3.2.1 Infusion catheters 115
8.3.2.2 IV/Administration sets 117
8.3.2.3 Needleless connectors 119
8.3.2.4 Cannulas 121
8.3.2.5 Tubing and extension sets 122
8.3.2.6 Valves 125
8.3.2.7 Other non-dedicated accessories/consumables 126

9 INFUSION PUMPS MARKET, BY APPLICATION 128
9.1 INTRODUCTION 129
9.2 CHEMOTHERAPY/ONCOLOGY 130
9.3 DIABETES 133
9.4 GASTROENTEROLOGY 135
9.5 ANALGESIA/PAIN MANAGEMENT 136
9.6 PEDIATRICS/NEONATOLOGY 138
9.7 HEMATOLOGY 139
9.8 OTHER APPLICATIONS 140

10 INFUSION PUMPS MARKET, BY END USER 142
10.1 INTRODUCTION 143
10.2 HOSPITALS 144
10.3 HOME CARE SETTINGS 145
10.4 AMBULATORY CARE SETTINGS 147
10.5 ACADEMIC & RESEARCH INSTITUTES 148
?

11 GLOBAL INFUSION PUMPS MARKET, BY REGION 150
11.1 INTRODUCTION 151
11.2 NORTH AMERICA 152
11.2.1 US 158
11.2.2 CANADA 163
11.3 EUROPE 168
11.3.1 GERMANY 174
11.3.2 FRANCE 179
11.3.3 UK 184
11.3.4 ITALY 188
11.3.5 SPAIN 193
11.3.6 ROE 197
11.4 APAC 202
11.4.1 JAPAN 208
11.4.2 CHINA 212
11.4.3 INDIA 217
11.4.4 ROAPAC 222
11.5 LATIN AMERICA 226
11.6 MIDDLE EAST & AFRICA 231

12 COMPETITIVE LANDSCAPE 236
12.1 OVERVIEW 236
12.2 REVENUE ANALYSIS (2016–2017) 237
12.3 GEOGRAPHIC REACH OF THE TOP MARKET PLAYERS (2017) 238
12.4 MARKET SHARE ANALYSIS 239
12.5 COMPETITIVE SITUATION AND TRENDS 240
12.5.1 COLLABORATIONS AND AGREEMENTS 240
12.5.2 PRODUCT LAUNCHES AND ENHANCEMENTS 242
12.5.3 EXPANSIONS 243
12.5.4 ACQUISITIONS 243
?

13 COMPANY PROFILES 244
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 BECTON, DICKINSON AND COMPANY (BD) 244
13.2 B. BRAUN MELSUNGEN 248
13.3 BAXTER INTERNATIONAL 255
13.4 FRESENIUS KABI 258
13.5 ICU MEDICAL 263
13.6 MEDTRONIC 267
13.7 MOOG INC. (MOOG) 271
13.8 SMITHS MEDICAL (A DIVISION OF SMITHS GROUP PLC) 274
13.9 TERUMO CORPORATION 277
13.10 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) 279
13.11 HALYARD HEALTH 281
13.12 MINDRAY MEDICAL INTERNATIONAL LIMITED 283
13.13 MICREL MEDICAL DEVICES 285
13.14 INSULET CORPORATION 286
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14 APPENDIX 288
14.1 INSIGHTS OF INDUSTRY EXPERTS 288
14.2 DISCUSSION GUIDE 289
14.2.1 QUESTIONNAIRE 289
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 294
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 296
14.5 AVAILABLE CUSTOMIZATIONS 298
14.6 RELATED REPORTS 299
14.7 AUTHOR DETAILS 300